Llwytho...
Lipoprotein(a) and inhibitors of proprotein convertase subtilisin/kexin type 9
Lipoprotein(a) [Lp(a)] has been identified as a risk factor for cardiovascular disease. Lp(a) levels are also high under certain clinical conditions, including familial hypercholesterolemia and high blood low-density lipoprotein (LDL) cholesterol levels. Few effective generic therapies for modulatin...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Thorac Dis |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
AME Publishing Company
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5303088/ https://ncbi.nlm.nih.gov/pubmed/28203441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2017.01.40 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|